CBIS / Cannabis Science, Inc. - Документы SEC, Годовой отчет, Доверенное заявление

Каннабис Сайенс, Инк.
US ˙ OTC
ЭТОТ СИМВОЛ БОЛЬШЕ НЕ АКТИВЕН

Основная статистика
CIK 1024626
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Cannabis Science, Inc.
SEC Filings (Chronological Order)
На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.
May 20, 2019 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 15, 2018 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission Fil

April 15, 2019 10-K/A

Annual Report - CBIS 10K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 2 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CAN

May 16, 2018 NT 10-Q

CBIS / Cannabis Science, Inc. NT10Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

April 6, 2018 NT 10-K

CBIS / Cannabis Science, Inc. CBIS NT 10K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

April 5, 2018 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 14, 2018 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File N

December 11, 2017 8-K

Entry into a Material Definitive Agreement

8-K 1 cbis-201712118k.htm CBIS 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 16, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction

November 20, 2017 10-Q

Quarterly Report - CANNABIS SCIENCE INC., 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SC

November 15, 2017 NT 10-Q

CBIS / Cannabis Science, Inc. CBIS NT 10Q

NT 10-Q 1 cbis-20171115nt10q.htm CBIS NT 10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form

October 31, 2017 8-K

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

October 31, 2017 EX-99.1

EX-99.1

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73

October 30, 2017 8-K

Regulation FD Disclosure, Other Events

8-K 1 cbis-201710308k.htm CBS 8K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction o

August 23, 2017 10-Q

CBIS / Cannabis Science, Inc. 10Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

August 14, 2017 NT 10-Q

Cannabis Science CBS NT10Q

NT 10-Q 1 cbis-20170804nt10q.htm CBS NT10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10

August 11, 2017 10-K/A

CBIS / Cannabis Science, Inc. CBIS 10K/A (Annual Report)

10-K/A 1 cbis-2016123110ka.htm CBIS 10K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period fr

August 11, 2017 10-Q

CBIS / Cannabis Science, Inc. CBIS 10Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2017 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

May 17, 2017 NT 10-Q

Cannabis Science NT10Q

NT 10-Q 1 cbis-20170517nt10q.htm NT10Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [

May 17, 2017 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 27, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File N

April 17, 2017 10-K

Cannabis Science CANNABIS SCIENCE, INC., 10-K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC

April 5, 2017 EX-99.1

CBIS Subsidiary, Cannabis Science Europe GmbH Acquires Majority Shares of German Bio Med GmbH Jinvator to Facilitate European Expansions, New Products, and Additional Clinical Studies

CBIS Subsidiary, Cannabis Science Europe GmbH Acquires Majority Shares of German Bio Med GmbH Jinvator to Facilitate European Expansions, New Products, and Additional Clinical Studies The Ground-Breaking Jinvator nanoGold test is the first and only early diagnostic test for HIV/AIDS! The nanoGold test gives HIV/AIDS no chance! IRVINE, CA- (April 5, 2017) - Cannabis Science, Inc.

April 5, 2017 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Nu

March 31, 2017 NT 10-K

Cannabis Science CANNABIS SCIENCE INC., NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

January 9, 2017 8-K

Entry into a Material Definitive Agreement, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 3, 2017 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

November 14, 2016 10-Q

Cannabis Science CANNABIS SCIENCE, INC., 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SC

September 28, 2016 EX-4.1

CANNABIS SCIENCE, INC. 2016 Equity Award Plan B

EX-4.1 2 exhibit4-1.htm EXHIBIT 4.1 CANNABIS SCIENCE, INC. 2016 Equity Award Plan B SECTION 1. PURPOSE AND EFFECTIVE DATE (a) Purpose. The Cannabis Science, Inc. 2016 Equity Award Plan B (the “Plan”) is intended to promote the interests of the Company and its shareholders by (i) promoting the growth and success of Cannabis Science, Inc. (the “Company”) by linking a significant portion of Participa

September 28, 2016 S-8

Cannabis Science S8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 19800 MacArthur Blvd., Suite #300 Irvine, California 92612 (Address of

September 20, 2016 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

` UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 14, 2016 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission

August 11, 2016 10-Q

Cannabis Science CANNABIS SCIENCE, INC., 10-Q (Quarterly Report)

10-Q 1 cbis-2016063010q.htm CANNABIS SCIENCE, INC., 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period f

August 11, 2016 EX-99.1

DEBT SETTLEMENT AGREEMENT

EX-99.1 6 exhibit99-1.htm EXHIBIT-99.1 EXHIBIT 99.1 DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 7th day of February 2016. BETWEEN: Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254, Colorado Springs, CO 80918 (the “Company”) OF THE FIRST PART AND: Stacey R. Lewis, having an address at 5539 West

July 1, 2016 8-K

Other Events

` UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2016 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

June 9, 2016 10-Q

Cannabis Science CANNABIS SCIENCE, INC., 10-Q (Quarterly Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2016 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

June 9, 2016 EX-99.1

DEBT SETTLEMENT AGREEMENT

EXHIBIT 99.1 DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 7th day of February 2016. BETWEEN: Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254, Colorado Springs, CO 80918 (the ?Company?) OF THE FIRST PART AND: Stacey R. Lewis, having an address at 5539 West Ave L6, Quartz Hill CA 93536 (the ?Cred

June 9, 2016 10-K/A

Cannabis Science CANNABIS SCIENCE, INC., 10-Q (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CAN

May 18, 2016 NT 10-Q

Cannabis Science CBIS, NT10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

May 9, 2016 10-K

Cannabis Science CBIS 10K (Annual Report)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC.

March 30, 2016 NT 10-K

Cannabis Science FORM NT 10-K

NT 10-K 1 formnt10k.htm FORM NT 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ]

March 4, 2016 EX-99.1

In an Unprecedented Move, Cannabis Science President & CEO, Mr. Raymond C. Dabney, to Gift his Personal Shares to Shareholders to Replace Both Previously Announced Dividends, to Personally Complete Promised Payments

Filed by OTC Filings Inc. - www.otcedgar.com - Cannabis Science, Inc. - Exhibit 99.1 In an Unprecedented Move, Cannabis Science President & CEO, Mr. Raymond C. Dabney, to Gift his Personal Shares to Shareholders to Replace Both Previously Announced Dividends, to Personally Complete Promised Payments COLORADO SPRINGS, Colo., March 4, 2016, Cannabis Science, Inc. (OTC: CBIS), a U.S. company speciali

March 4, 2016 8-K

Regulation FD Disclosure, Financial Statements and Exhibits

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2016 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorpor

February 27, 2016 S-8

Cannabis Science FORM S-8

S-8 1 forms8.htm FORM S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization) (I.R.S. Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorad

February 27, 2016 EX-4.1

CANNABIS SCIENCE, INC. 2016 EQUITY AWARD PLAN

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Exhibit 4.1 CANNABIS SCIENCE, INC. 2016 EQUITY AWARD PLAN SECTION 1. PURPOSE AND EFFECTIVE DATE (a) Purpose. The Cannabis Science, Inc. 2016 Equity Award Plan (the ?Plan?) is intended to promote the interests of the Company and its shareholders by (i) promoting the growth and success of Cannabis Science

November 24, 2015 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 [ ] TRA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001

November 23, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 [ ] TRANSITION REPORT PUR

10-Q 1 form10q.htm FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File

November 16, 2015 NT 10-Q

Cannabis Science FORM NT 10-Q

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Form NT10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: October 31, 2018 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] F

November 2, 2015 DEF 14C

Cannabis Science FORM DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) x Definitive Information Statement CANNABIS SCIENCE, INC.

October 19, 2015 PRE 14C

Cannabis Science PRE 14

PRE 14C 1 formpre14c.htm PRE 14 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitiv

October 9, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2015 [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

September 17, 2015 DEF 14C

Cannabis Science FORM DEF 14C

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Form DEF 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, f

September 3, 2015 PRE 14C

Cannabis Science FORM PRE 14C

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Form Pre 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, f

August 18, 2015 8-K

Other Events

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 17, 2015 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorp

August 18, 2015 S-8

Cannabis Science FORM S-8

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization)

August 18, 2015 EX-4.1

CANNABIS SCIENCE, INC. 2015 EQUITY AWARD PLAN

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Exhibit 4.1 CANNABIS SCIENCE, INC. 2015 EQUITY AWARD PLAN SECTION 1. PURPOSE AND EFFECTIVE DATE (a) Purpose. The Cannabis Science, Inc. 2015 Equity Award Plan (the ?Plan?) is intended to promote the interests of the Company and its shareholders by (i) promoting the growth and success of Cannabis Science

August 17, 2015 NT 10-Q

Cannabis Science FORM NT 10-Q

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Form NT10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Fo

July 28, 2015 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2015 [ ] TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2015 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

June 30, 2015 EX-10.1

Cannabis Science Research Foundation and Cannabis Science Inc., CONSULTING AGREEMENT

Filed by OTC Filings Inc. - www.otcedgar.com - Cannabis Science, Inc. - Exhibit 10.1 Cannabis Science Research Foundation and Cannabis Science Inc., CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the June 29, 2015 (the ?Effective Date?), entered into between Cannabis Science Research Foundation a California Non Profit Corporation, with its principal registered address of Sui

June 30, 2015 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

Filed by OTC Filings Inc. - www.otcedgar.com - Cannabis Science, Inc. - Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 29, 2015 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28

June 11, 2015 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 [ ] TRANSITION RE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CAN

May 27, 2015 8-K

Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 21, 2015 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Num

May 18, 2015 NT 10-Q

Cannabis Science FORM NT 10-Q

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Form NT10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Fo

April 21, 2015 EX-10.21

CONSULTING AGREEMENT

CONSULTING AGREEMENT This Consulting Agreement (the “Agreement”) dated as of February 20th, 2015 (the “Effective Date”) is made by and between Michigan Green Technologies LLC with address 31355 W.

April 21, 2015 EX-10.2

AMENDMENT TO MANAGEMENT AGREEMENT DATED FEBRUARY 9, 2012 BETWEEN CANNABIS SCIENCE, INC. AND BRET BOGUE (THE “AMENDMENT”)

AMENDMENT TO MANAGEMENT AGREEMENT DATED FEBRUARY 9, 2012 BETWEEN CANNABIS SCIENCE, INC.

April 21, 2015 EX-10.12

EXECUTIVE MANAGEMENT AGREEMENT

EXECUTIVE MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") dated November 25, 2014 and effective as of January 1, 2015 (the “Effective Date”), is entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.11

INDEPENDENT CONSULTING AGREEMENT

INDEPENDENT CONSULTING AGREEMENT THIS INDEPENDENT CONSULTING AGREEMENT (the "Agreement") effective as of the day of 1st day of January, 2015 (the Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.16

CONSULTING MANAGEMENT AGREEMENT

CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 26, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.7

MANAGEMENT AGREEMENT AMENDMENT TO NOVEMBER 19, 2014 CONSULTING AGREEMENT BETWEEEN THE BIO DIVERSITY GROUP AND CANNABIS SCIENCE, INC.

MANAGEMENT AGREEMENT AND AMENDMENT TO NOVEMBER 19, 2014 CONSULTING AGREEMENT BETWEEEN THE BIO DIVERSITY GROUP AND CANNABIS SCIENCE, INC.

April 21, 2015 EX-10.17

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 20th day of February, 2015.

April 21, 2015 EX-10.1

AMENDMENT TO FEBRUARY 9, 2012 LICENSE AGREEMENT (hereinafter the “Agreement”)

AMENDMENT TO FEBRUARY 9, 2012 LICENSE AGREEMENT (hereinafter the ?Agreement?) BETWEEN: CANNABIS SCIENCE, INC.

April 21, 2015 EX-10.14

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 15th day of January 2015.

April 21, 2015 EX-10.18

CONSULTING AGREEMENT

CONSULTING AGREEMENT This Consulting Agreement (the “Agreement”) dated as of February 20th, 2015 (the “Effective Date”) is made by and between Michigan Green Technologies LLC with address 31355 W.

April 21, 2015 EX-10.9

ADDENDUM TO CONSULTING AGREEMENT

ADDENDUM TO CONSULTING AGREEMENT THIS ADDENDUM to Consulting Agreement made effective as of the 13th of November, 2014 (the “Effective Date”) BETWEEN: CANNABIS SCIENCE, INC.

April 21, 2015 EX-10.4

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Twentieth-Fifth (25th) day of November 2014 (the ?Effective Date?), is entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.3

CONSULTING AGREEMENT

CONSULTING AGREEMENT This Agreement is made and entered into effect November 19, 2014 by and between THE BIO DIVERSITY GROUP and CANNABIS SCIENCE, INC.

April 21, 2015 EX-10.24

CONSULTING MANAGEMENT AGREEMENT

CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 16, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.19

CONSULTING AGREEMENT

CONSULTING AGREEMENT This Consulting Agreement (the “Agreement”) dated as of February 20th, 2015 (the “Effective Date”) is made by and between Michigan Green Technologies LLC with address 31355 W.

April 21, 2015 EX-10.15

EXECUTIVE MANAGEMENT AGREEMENT

EX-10.15 16 exhibit1015.htm EXHIBIT 10.15 EXECUTIVE MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") dated January 19, 2015 and effective as of January 20, 2015 (the “Effective Date”), is entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal registered address of 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 USA and email: raymond@canna

April 21, 2015 EX-10.23

[Signature Page Follows]

CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 16, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.26

CONSULTING MANAGEMENT AGREEMENT

CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 16, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.8

- 1 - ADDENDUM TO CONSULTING AGREEMENT

- 1 - ADDENDUM TO CONSULTING AGREEMENT THIS ADDENDUM to Consulting Agreement made effective as of the 13th of November, 2014 (the “Effective Date”) BETWEEN: CANNABIS SCIENCE, INC.

April 21, 2015 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 [ ] TRANSITION REPORT PURSUANT TO S

10-K 1 form10k.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 00

April 21, 2015 EX-10.20

CONSULTING AGREEMENT

CONSULTING AGREEMENT This Consulting Agreement (the ?Agreement?) dated as of February 20th, 2015 (the ?Effective Date?) is made by and between Michigan Green Technologies LLC with address 31355 W.

April 21, 2015 EX-10.25

CONSULTING MANAGEMENT AGREEMENT

EX-10.25 26 exhibit1025.htm EXHIBIT 10.25 CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 16, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal registered address of 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 USA email: [email protected] (the “Compa

April 21, 2015 EX-10.27

CONSULTING MANAGEMENT AGREEMENT

EX-10.27 28 exhibit1027.htm EXHIBIT 10.27 CONSULTING MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 26, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal registered address of 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 USA email: [email protected] (the “Compa

April 21, 2015 EX-10.28

CONSULTING PRODUCTION MANAGEMENT AGREEMENT

CONSULTING PRODUCTION MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the March 26, 2015 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.10

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 18th day of December, 2014.

April 21, 2015 EX-10.22

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the fourteenth (14th) day of October, 2014 (the “Effective Date”), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.5

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Twentieth-Fifth (25th) day of November 2014 (the “Effective Date”), is entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.6

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Twentieth (20th) day of November 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

April 21, 2015 EX-10.13

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the fifteenth (15th) day of January 2015 (the ?Effective Date?), entered into between Cannabis Science, Inc.

April 1, 2015 NT 10-K

Cannabis Science FORM NT 10-K

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE(3453) - Cannabis Science, Inc. - Form NT10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ]

March 25, 2015 EX-4.1

CANNABIS SCIENCE, INC. 2015 Stock Compensation Plan SECTION 1

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Exhibit 4.1 CANNABIS SCIENCE, INC. 2015 Stock Compensation Plan SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the ?Company?), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2015 Non-qualified Stock Compensation Plan (the ?Plan?) for employees, consultants, direct

March 25, 2015 S-8

Cannabis Science FORM S-8

Filed by OTC Filings Inc. - www.otcedgar.com - 1-866-832-FILE (3453) - CANNABIS SCIENCE, INC. - Form S-8 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization)

December 5, 2014 EX-4.1

CANNABIS SCIENCE, INC.

CANNABIS SCIENCE, INC. 2014 Stock Compensation Plan C SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the “Company”), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2014 Non-qualified Stock Compensation Plan C (the “Plan”) for employees, consultants, directors, and other persons associated with the Company and any of the Company’s subsidiaries, whom the Board

December 5, 2014 S-8

CBIS / Cannabis Science, Inc. S-8 - - FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization) (I.R.S. Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorado Springs, Colorado 80918

November 24, 2014 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 20, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission Fil

November 19, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 [ ] TRANSITION REPORT PUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SC

November 19, 2014 EX-99.1

MANAGEMENT AGREEMENT

EX-99.1 6 exhibit991.htm EXHIBIT 99.1 MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the first (1st) day of June 2012 (the “Effective Date”), entered into between Cannabis Science, Inc. a Nevada Corporation, with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and Dr. Roscoe Moore Jr., with an

November 19, 2014 EX-99.6

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Fifth (5th) day of November 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

November 19, 2014 EX-99.7

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Twenty Forth (24th) day of October 2014 (the “Effective Date”), entered into between Cannabis Science, Inc.

November 19, 2014 EX-99.2

EXECUTIVE MANAGEMENT AGREEMENT

EX-99.2 7 exhibit992.htm EXHIBIT 99.2 EXECUTIVE MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the 23rd day of October, 2014 (the “Effective Date”), entered into between Cannabis Science, Inc., a Nevada Corporation, with its principal registered address of 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 USA email: [email protected] (the

November 19, 2014 EX-99.2

1

Cannabis Science Inc. 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918 Telephone: 1.888.889.0888 Fax: 1.866.943.5085 [email protected] August 6, 2014 John Dalaly 31355 W. 13 Mile Road Farmington Hills, MI 48334 Re: Proposal for Equity in Michigan Green Technologies, LLC Dear John: Please accept this letter as an official offer from Cannabis Science (?CBIS?) to acquire an additio

November 19, 2014 EX-99.5

CONSULTING AGREEMENT

CONSULTING AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the fifth (5th) day of November, 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

November 14, 2014 NT 10-Q

CBIS / Cannabis Science, Inc. NT 10-Q - - FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

November 6, 2014 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

October 10, 2014 EX-4.1

CANNABIS SCIENCE, INC. 2014 Stock Compensation Plan B SECTION 1

EX-4.1 2 exhibit41.htm EXHIBIT 4.1 CANNABIS SCIENCE, INC. 2014 Stock Compensation Plan B SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the “Company”), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2014 Non-qualified Stock Compensation Plan B (the “Plan”) for employees, consultants, directors, and other persons associated with the Company and any of the Com

October 10, 2014 S-8

CBIS / Cannabis Science, Inc. S-8 - - FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization) (I.R.S. Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorado Springs, Colorado 80918

September 12, 2014 8-K

Entry into a Material Definitive Agreement, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 1, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission Fil

September 12, 2014 EX-10.1

HEAD OF JOINT VENTURE VIABILITY AND OPERATING AGREEMENT CANNABIS SCIENCE INC. UNISTRAW HOLDINGS PTE. LTD.

HEAD OF JOINT VENTURE VIABILITY AND OPERATING AGREEMENT BETWEEN CANNABIS SCIENCE INC.

September 5, 2014 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 [ ] TRANSITI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-2891

September 5, 2014 EX-10.2

SENIOR ADVISOR AGREEMENT

SENIOR ADVISOR AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the day of 1st day of June, 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

September 5, 2014 EX-10.1

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the twenty-fifth (25th) day of June, 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

September 2, 2014 DEF 14C

CBIS / Cannabis Science, Inc. DEF 14C - - FORM DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) x Definitive Information Statement CANNABIS SCIENCE, INC.

August 18, 2014 EX-10.2

SENIOR ADVISOR AGREEMENT

EX-10.2 3 exhibit102.htm EXHIBIT 10.2 SENIOR ADVISOR AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the day of 1st day of June, 2014 (the “Effective Date”), entered into between Cannabis Science, Inc., with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and Dr. Roscoe M. Moore Jr., with an address of wit

August 18, 2014 EX-10.1

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the twenty-fifth (25th) day of June, 2014 (the ?Effective Date?), entered into between Cannabis Science, Inc.

August 18, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

August 14, 2014 EX-3.1

EX-3.1

August 14, 2014 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

August 14, 2014 8-K

Material Modification to Rights of Security Holders, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 12, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

August 14, 2014 PRE 14C

CBIS / Cannabis Science, Inc. PRE 14C - - FORM PRE 14C

PRE 14C 1 formpre14c.htm FORM PRE 14C UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Def

August 8, 2014 8-K

Entry into a Material Definitive Agreement

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File N

June 4, 2014 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 [ ] TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: March 31, 2014 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

June 2, 2014 8-K

Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

8-K 1 f8k052014cannabisscience.htm CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2014 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other j

May 16, 2014 NT 10-Q

- FORM NT 10-Q

NT 10-Q 1 formnt10q.htm FORM NT 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ]

April 28, 2014 S-8

- FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or Other Jurisdiction of Incorporation of Organization) (I.R.S. Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorado Springs, Colorado 80918

April 28, 2014 EX-4.1

CANNABIS SCIENCE, INC. 2014 STOCK COMPENSATION SECTION 1

CANNABIS SCIENCE, INC. 2014 STOCK COMPENSATION SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the “Company”), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2014 Non-qualified Stock Plan (the “Plan”) for employees, consultants, directors, and other persons associated with the Company and any of the Company’s subsidiaries, whom the Board wishes to incite. 1.2

April 23, 2014 EX-10.1

DEBT SETTLEMENT AGREEMENT

EX-10.1 2 ex101.htm EXHIBIT 10.1 DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 5th day of November 2013. BETWEEN: Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918 (the “Company”) OF THE FIRST PART AND: Intrinsic Venture Corp., a company incorporated under the laws of Br

April 23, 2014 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 [ ] TRANSITION RE

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CAN

April 23, 2014 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 [ ] TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC

April 23, 2014 EX-10.2

CONSULTING AGREEMENT BETWEEN AMANDIP JAGPAL AND CANNABIS SCIENCE, INC.

EX-10.2 3 ex102.htm EXHIBIT 10.2 CONSULTING AGREEMENT BETWEEN AMANDIP JAGPAL AND CANNABIS SCIENCE, INC. This CONSULTING AGREEMENT (“Agreement”) is entered into this 5th day of November 2013 by and between Amandip Jagpal, (“AJ” or “Consultant”), and CANNABIS SCIENCE, INC., (“CSI” or “Company”) a Nevada Corporation. WHEREAS, the Company is engaged in the business of working with World Authorities on

March 31, 2014 NT 10-K

- FORM NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

January 27, 2014 SC 13G/A

CBIS / Cannabis Science, Inc. / Cowan Richard C. - AMENDMENT NO. 1 Passive Investment

SC 13G/A 1 cowan13ga1.htm AMENDMENT NO. 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Cannabis Science, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 137648101 (CUSIP Number) December 31, 2013 (Date of Event which Requires Filing of this Statement) Check the appropriate box to

November 22, 2013 144

- FORM 144

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933 ATTENTION: Transmit for filing 3 copies of this form concurrently with either placing an order with a broker to execute sale or executing a sale directly with a market maker. 1 (a) NAME OF ISSUER (Please type or print) Cannabis

November 20, 2013 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 [ ] TRA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001

November 20, 2013 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 [ ] TRA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 2 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001

November 19, 2013 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 [ ] TRANSITION REPORT PUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: September 30, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SC

November 18, 2013 SC 13D

CBIS / Cannabis Science, Inc. / Melamede Robert - FORM SCHEDULE 13D Activist Investment

SC 13D 1 schedule13d.htm FORM SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13D Under the Securities Exchange Act of 1934 (Amendment No. ) Cannabis Science, Inc. (Name of Issuer) Common Stock, $.001 par value (Title of Class of Securities) 137648101 (CUSIP Number) Dr. Robert Melamede c/o Cannabis Science, Inc. 6946 N. Academy Blvd., Suite B #254 Colo

November 15, 2013 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

September 18, 2013 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended: June 30, 2013 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

September 3, 2013 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2013. ( ) TRANSIT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2013. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-289

August 29, 2013 EX-10.1

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the twentieth (20th) day of May 2013 (the “Effective Date”), entered into between Cannabis Science, Inc.

August 29, 2013 EX-10.2

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the Twenty-Fourth (24th) Day of June 2013 (the “Effective Date”), entered into between Cannabis Science, Inc.

August 29, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits

8-K 1 form8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2013 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorpora

August 23, 2013 EX-10.2

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 13th day of February 2013.

August 23, 2013 EX-10.1

ASSET PURCHASE AGREEMENT

EX-10.1 2 ex101.htm EXHIBIT 10.1 ASSET PURCHASE AGREEMENT AGREEMENT, dated as of February 8, 2013 among Cannabis Science, Inc., a Nevada corporation (the "Seller"), and The X-Change Corporation, a Delaware corporation (the "Purchaser"). RECITALS A. Seller is the owner of various assets related to the use of cannabis including resale formulas, media, activism and marketing videos and other items (A

August 23, 2013 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2013. ( ) TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2013. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

August 23, 2013 EX-10.3

MANAGEMENT AGREEMENT

EX-10.3 4 ex103.htm EXHIBIT 10.3 MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the day of 1st day of January, 2013 (the “Effective Date”), entered into between Cannabis Science, Inc., with its principal offices located at 6946 North Academy Blvd Suite B #254, Colorado Springs, Colorado 80918 (the “Company” or “CBIS”) and Bogat Family Trust, with an address of #503 1155 Robs

August 15, 2013 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

June 17, 2013 EX-10.1

MANAGEMENT AGREEMENT

MANAGEMENT AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the twentieth (20th) day of May 2013 (the “Effective Date”), entered into between Cannabis Science, Inc.

June 17, 2013 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2013 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Num

May 16, 2013 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

May 3, 2013 SC 13G

CBIS / Cannabis Science, Inc. / Cowan Richard C. - CANNABIS SCIENCE, INC. Passive Investment

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Cannabis Science, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 137648101 (CUSIP Number) April 24, 2012** (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Sc

April 23, 2013 EX-4.1

CERTIFICATE OF CHANGE PURSUANT NRS 78.209 NEVADA PROFIT CORPORATIONS

EXHIBIT (4)(1) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: secretaryofstate.

April 23, 2013 EX-3.14

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuance of Stock)

EX-3.14 4 fe0314.htm EXHIBIT 3.14 EXHIBIT (3)(1)(iv) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: secretaryofstate.biz FILED: 02:11PM 03/18/2008 Document #: 20080186077-19 Entity #: E0315782007-3 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FOR NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issu

April 23, 2013 EX-2.1

ARTICLES OF CONVERSION (Pursuant to NRS 92A.205)

EXHIBIT (2)(1) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: secretaryofstate.

April 23, 2013 EX-3.13

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.380 ? Before Issuance of Stock)

EXHIBIT (3)(1)(iii) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: secretaryofstate.

April 23, 2013 EX-10.2

ASSET PURCHASE AGREEMENT

ASSET PURCHASE AGREEMENT AGREEMENT, dated as of December 11, 2012 among Cannabis Science, Inc.

April 23, 2013 EX-3.18

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuance of Stock)

EX-3.18 8 fex0318.htm EXHIBIT 3.18 EXHIBIT (3)(1)(viii) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: www.nvsos.gov FILED: 12:30 PM 11/21/2011 Document #: 20110824328-61 Entity #: E0315782007-3 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FOR NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuanc

April 23, 2013 EX-4.2

CERTIFICATE OF DESIGNATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.1955)

EX-4.2 10 fe0412.htm EXHIBIT 4.2 EXHIBIT (4)(2) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: www.nvsos.gov FILED: 4:00 PM 09/08/2009 Document #: 20090669232-69 Entity #: E0315782007-3 CERTIFICATE OF DESIGNATION FOR NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.1955) 1. Name of Corporation: Cannabis Science, Inc. 2. By resolut

April 23, 2013 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 [ ] TRANSITION REPORT PURSUANT TO S

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2012 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC

April 23, 2013 EX-10.1

DEBT SETTLEMENT AGREEMENT

EX-10.1 11 fex101.htm EXHIBIT 10.1 DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 19th day of October 2012. BETWEEN: Cannabis Science, Inc., a company incorporated under the laws of Nevada and having an office at 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918 (the “Company”) OF THE FIRST PART AND: Munro Holdings S.A., a company incorporated under the laws of Beli

April 23, 2013 EX-3.17

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 ? After Issuance of Stock)

EXHIBIT (3)(1)(vii) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: www.

April 23, 2013 EX-3.15

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuance of Stock)

EX-3.15 5 fe0315.htm EXHIBIT 3.15 EXHIBIT (3)(1)(v) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: www.nvsos.gov FILED: 03:00PM 04/06/2009 Document #: 20090324938-90 Entity #: E0315782007-3 CERTIFICATE OF AMENDMENT TO ARTICLES OF INCORPORATION FOR NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuance of

April 23, 2013 EX-3.16

CERTIFICATE OF AMENDMENT ARTICLES OF INCORPORATION NEVADA PROFIT CORPORATIONS (Pursuant to NRS 78.385 and 78.390 – After Issuance of Stock)

EXHIBIT(3)(1)(vi) Ross Miller Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 89707-4299 (775) 684-5708 Website: www.

April 2, 2013 NT 10-K

- FORM NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

December 31, 2012 EX-99.1

ASSET PURCHASE AGREEMENT

ASSET PURCHASE AGREEMENT AGREEMENT, dated as of December 11, 2012 among Cannabis Science, Inc.

December 31, 2012 EX-99.2

ADDENDUM TO JOINT VENTURE OPERATING AGREEMENT

ADDENDUM TO JOINT VENTURE OPERATING AGREEMENT THIS ADDENDUM to Joint Venture Operating Agreement made effective as of the 12th day of December 2012 (the “Effective Date”) BETWEEN: CANNABIS SCIENCE, INC.

December 31, 2012 8-K

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement, Financial Statements and Exhibits - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 12, 2012 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission Fil

November 21, 2012 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2012. ( ) TRA

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2012. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001

November 19, 2012 EX-10.3

DONALD SHAXON AND CANNABIS SCIENCE INC.

CONSULTING AGREEMENT BETWEEN DONALD SHAXON AND CANNABIS SCIENCE INC. This CONSULTING AGREEMENT (“Agreement”) is entered into this 11th day of July 2012 by and between DON SHAXON(“SHAXON” OR “CONSULTANT”), a resident of Burlington, Ontario, Canada, and CANNABIS SCIENCE INC.(“CSI”), a Nevada Corporation. 1. Purpose. This Agreement is established between the parties for the purpose of DONALD SHAXON p

November 19, 2012 EX-10.1

CANNABIS SCIENCE INC. dupetit Natural Products GmbH JOINT VENTURE OPERATING AGREEMENT

EX-10.1 2 exhibit101.htm EXHIBIT 10.1 CANNABIS SCIENCE INC. & dupetit Natural Products GmbH JOINT VENTURE OPERATING AGREEMENT JOINT VENTURE OPERATING AGREEMENT FOR CANNABIS SCIENCE INC. & dupetit Natural Products GmbH THIS JOINT VENTURE OPERATING AGREEMENT ("Agreement" or “JV”) is entered into as of the 27th day of July 2012, by Cannabis Science Inc. and dupetit Natural Products GmbH (the “Compani

November 19, 2012 EX-99.1

EIGHTH JUDICIAL DISTRICT COURT CLARK COUNTY, NEVADA CANNABIS SCIENCE, INC, a Nevada corporation, Plaintiff, vs. GOLDSMITH HEALTH CARE, LTD., a Nevada professional corporation; IVAN GOLDSMITH, M.D., individual; MONA DEVER-GOLDSMITH, an individual; DOE

EX-99.1 9 exhibit991.htm EXHIBIT 99.1 JACOB L. HAFTER, ESQ. Nevada State Bar No. 9303 MICHAEL K. NAETHE, ESQ. Nevada State Bar No. 11222 LAW OFFICE OF JACOB L. HAFTER & ASSOCIATES 7201 W. Lake Mead Boulevard, Suite 210 Las Vegas, Nevada 89128 Tel: (702) 405-6700 Fax: (702) 685-4184 Attorneys for Cannabis Science, Inc. EIGHTH JUDICIAL DISTRICT COURT CLARK COUNTY, NEVADA CANNABIS SCIENCE, INC, a Nev

November 19, 2012 EX-10.2

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENTis dated for reference the 13th day of July 2012.

November 19, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2012. ( ) TRANSITION REPORT PUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2012. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SC

November 15, 2012 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2015 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

October 1, 2012 8-K

Entry into a Material Definitive Agreement - FORM 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 10, 2012 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission Fi

August 20, 2012 EX-10.4

DEBT SETTLEMENT AGREEMENT

DEBT SETTLEMENT AGREEMENT THIS AGREEMENT is dated for reference the 1st day of December 2011.

August 20, 2012 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 TRANSITION REPORT PURSUANT TO

10-K 1 csi10k2011.htm FORM 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number:

August 20, 2012 EX-10.2

CANNABIS SCIENCE LICENSING AGREEMENT

EX-10.2 3 exhibit102.htm EXHIBIT 10.2 CANNABIS SCIENCE LICENSING AGREEMENT BETWEEN: CANNABIS SCIENCE, INC., a Nevada Corporation, with its corporate offices located at 6946 N Academy Blvd Suite B #254 Colorado Springs, CO 80918. (the “Licensor") AND: APOTHECARY GENETICS INVESTMENTS LLC., a California Corporation, with its corporate offices located at 30211 Avenida De Las Banderas Ste 200, Rancho S

August 20, 2012 EX-10.3

SHARE PURCHASE AGREEMENT

SHARE PURCHASE AGREEMENT This Share Purchase Agreement ("Agreement") is entered into as of January 1, 2012 by and between: Cannabis Science, Inc.

August 20, 2012 EX-10.4

SHARE PURCHASE AGREEMENT

SHARE PURCHASE AGREEMENT This Share Purchase Agreement ("Agreement") is entered into as of March 9, 2012 by and between: Cannabis Science Inc.

August 20, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2012. ( ) TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2012. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

August 20, 2012 EX-10.1

MANAGEMENT BONUS AGREEMENT

MANAGEMENT BONUS AGREEMENT THIS AGREEMENT (the "Agreement") effective as of the day of 10th day of February, 2012 (the ?Effective Date?), entered into between Cannabis Science, Inc.

August 20, 2012 EX-10.1

NON-EXCLUSIVE COMMERCICAL LICENSE AGREEMENT

EX-10.1 2 f101.htm EXHIBIT 10.1 NON-EXCLUSIVE COMMERCICAL LICENSE AGREEMENT BETWEEN: CANNABIS SCIENCE, INC., a Nevada Corporation, with its corporate offices located at 2422 S. Trenton Way, Unit H, Denver, CO 80231. (the “Licensor") AND: ROCKBROOK INC., a Colorado Corporation, with its corporate offices located at Suite #323 - 2865 South Colorado Blvd Denver, CO 80222. (the "Licensee") WHEREAS: A.

August 20, 2012 EX-99.1 CHARTER

CANNABIS SCIENCE, INC. 2012 STOCK COMPENSATION SECTION 1

CANNABIS SCIENCE, INC. 2012 STOCK COMPENSATION SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the ?Company?), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2012 Non-qualified Stock Plan (the ?Plan?) for employees, consultants, directors, and other persons associated with the Company and any of the Company?s subsidiaries, whom the Board wishes to incite. 1.2

August 20, 2012 EX-10.3

MUTUAL TERMINATION AGREEMENT THIS MUTUAL TERMINATION AGREEMENTeffective as of the 30th day of July, 2010,

MUTUAL TERMINATION AGREEMENT THIS MUTUAL TERMINATION AGREEMENTeffective as of the 30th day of July, 2010, BETWEEN: CANNABIS SCIENCE, INC.

August 20, 2012 EX-99.2 BYLAWS

CANNABIS SCIENCE, INC. 2011 STOCK COMPENSATION PLAN SECTION 1

CANNABIS SCIENCE, INC. 2011 STOCK COMPENSATION PLAN SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the ?Company?), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2011 Non-qualified Stock Plan (the ?Plan?) for employees, consultants, directors, and other persons associated with the Company and any of the Company?s subsidiaries, whom the Board wishes to incite

August 20, 2012 EX-10.2

AMENDMENT AGREEMENT

AMENDMENT AGREEMENT THIS AMENDMENT AGREEMENT to the Management Agreement dated as of December 7, 2010 (the ?Effective Date?), is entered into between Cannabis Science, Inc.

August 20, 2012 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2012. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-289

August 15, 2012 NT 10-Q

- FORM NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: August 31, 2012 Estimated average burden hours per response.... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period

August 6, 2012 EX-99.1 CHARTER

EIGHTH JUDICIAL DISTRICT COURT CLARK COUNTY, NEVADA

EX-99.1 CHARTER 2 exhibita.htm EXHIBIT 99.1 JACOB L. HAFTER, ESQ. Nevada State Bar No. 9303 MICHAEL K. NAETHE, ESQ. Nevada State Bar No. 11222 LAW OFFICE OF JACOB L. HAFTER & ASSOCIATES 7201 W. Lake Mead Boulevard, Suite 210 Las Vegas, Nevada 89128 Tel: (702) 405-6700 Fax: (702) 685-4184 Attorneys for Cannabis Science, Inc. EIGHTH JUDICIAL DISTRICT COURT CLARK COUNTY, NEVADA CANNABIS SCIENCE, INC,

August 6, 2012 8-K

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 31, 2012 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Nu

May 21, 2012 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2012. ( ) TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2012. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

May 16, 2012 NT 10-Q

- FORM NT-10Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period Ended: March 31, 2012 [ ] Transition Report on Form 10-K [ ] Transition Report on Form 20-F [ ] Transition Report on Form 11-K [ X ] Transition Report on Form 10-

April 16, 2012 EX-99.1 CHARTER

99.1 Pro Forma Combined Financial Statements for GGECO University, Inc.

EXHIBIT 99.1 PRO FORMA FINANCIAL STATEMENTS SHOWING THE COMBINED RESULTS FOR CANNABIS SCIENCE, INC. AND GGECO UNIVERSITY, INC. FOR THE YEAR ENDED DECEMBER 31, 2011 CANNABIS SCIENCE, INC. (?CSI?) PRO FORMA CONSOLIDATED BALANCE SHEET Based on historical data and reflect adjustments for the separate companies for the year ended December 31, 2011 (unaudited). CSI GGECO ADJUSTMENTS REF. PRO FORMA CONSO

April 16, 2012 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2011 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC. (Exact name of reg

April 2, 2012 NT 10-K

- FORM NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

February 14, 2012 EX-4.1

CANNABIS SCIENCE, INC. 2012 STOCK COMPENSATION SECTION 1

CANNABIS SCIENCE, INC. 2012 STOCK COMPENSATION SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the “Company”), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2012 Non-qualified Stock Plan (the “Plan”) for employees, consultants, directors, and other persons associated with the Company and any of the Company’s subsidiaries, whom the Board wishes to incite. 1.2

February 14, 2012 S-8

- FORM S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorado Springs, CO 80918 (Address

November 21, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2011. ( ) TRANSIT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2011.

November 15, 2011 8-K

Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 3, 2011 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File

November 15, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

September 19, 2011 EX-4.1

CANNABIS SCIENCE, INC. 2011 STOCK COMPENSATION PLAN B SECTION 1

CANNABIS SCIENCE, INC. 2011 STOCK COMPENSATION PLAN B SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the ?Company?), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2011 Non-qualified Stock Plan B (the ?Plan?) for employees, consultants, directors, and other persons associated with the Company and any of the Company?s subsidiaries, whom the Board wishes to in

September 19, 2011 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 2422 S. Trenton Way, Unit H, Denver, CO 80231 (Address of principal ex

September 16, 2011 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended: June 30, 2011 [ ] TRANSITI

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended: June 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-2891

August 18, 2011 DEF 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: o Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) x Definitive Information Statement CANNABIS SCIENCE, INC.

August 16, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

August 16, 2011 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

August 16, 2011 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

August 16, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended: June 30, 2011 [ ] TRANSITION REPORT PURSUANT

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended: June 30, 2011 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

July 26, 2011 PRER14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement CANNABIS SCIENCE, INC.

July 25, 2011 CORRESP

VIA EDGAR

VIA EDGAR July 25, 2011 Anne Nguyen Parker, Branch Chief United States Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20002 (Tel) 202-551-3611 (Fax) 703-813-6982 Dear Ms.

July 13, 2011 CORRESP

VIA EDGAR

VIA EDGAR July 13, 2011 Anne Nguyen Parker, Branch Chief United States Securities and Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20002 (Tel) 202-551-3611 (Fax) 703-813-6982 Dear Ms.

July 13, 2011 PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION 100 F Street NE WASHINGTON, DC 20002 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement CANNABIS SCIENCE, INC.

June 10, 2011 PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14c-5 (d)(2)) o Definitive Information Statement CANNABIS SCIENCE, INC.

June 10, 2011 CORRESP

VIA EDGAR

VIA EDGAR June 9, 2011 Anne Nguyen Parker, Branch Chief United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 (Tel) 202-551-3611 (Fax) 703-813-6982 Dear Ms.

May 13, 2011 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2011. ( ) TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2011. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

May 13, 2011 PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C/A Amendment NO. 1 (RULE 14c-101) SCHEDULE 14C/A INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C/A Amendment NO.

May 12, 2011 CORRESP

1

VIA EDGAR May 12, 2011 Anne Nguyen Parker, Branch Chief United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 (Tel) 202-551-3611 (Fax) 703-813-6982 Dear Ms.

April 15, 2011 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2010 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC. (Exact name of reg

April 1, 2011 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ X ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

February 1, 2011 CORRESP

Cannabis Science Inc.

Cannabis Science Inc. 6946 N Academy Blvd., Suite B 254 Colorado Springs, CO 80918 Telephone: 1.888.889.0888 Ffax: 1.866.943.5085 [email protected] VIA EDGAR February 1, 2011 Anne Nguyen Parker, Branch Chief United States Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, DC 20549 (Tel) 202-551-3611 (Fax) 703-813-6982 Dear Ms. Anne Nguyen Parker, S

January 25, 2011 EX-4.1

2011 Stock Compensation Plan

EX-4.1 2 exhibit41.htm EXHIBIT 4.1 CANNABIS SCIENCE, INC. 2011 STOCK COMPENSATION PLAN SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the “Company”), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2011 Non-qualified Stock Plan (the “Plan”) for employees, consultants, directors, and other persons associated with the Company and any of the Company’s subsidiari

January 25, 2011 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other j

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 6946 N Academy Blvd, Suite B #254 Colorado Springs CO 80918 (Address o

December 21, 2010 PRE 14C

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 14C (RULE 14c-101) SCHEDULE 14C INFORMATION INFORMATION STATEMENT PURSUANT TO SECTION 14 (C) OF THE SECURITIES EXCHANGE ACT OF 1934 Check the appropriate box: x Preliminary Information Statement o Confidential, for Use of the Commission Only (as pe rmitted by Rule 14c-5 (d)(2)) o Definitive Information Statement CANNABIS SCIENCE, INC.

November 22, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2010. ( ) TRANSITION REPORT PUR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended September 30, 2010. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SC

November 16, 2010 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

August 23, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2010.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended June 30, 2010. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENCE

August 17, 2010 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Period En

May 24, 2010 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2010. ( ) TRANSITION REPORT PURSUAN

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (X) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the quarterly period ended March 31, 2010. OR ( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 for the transition period from to Commission File Number: 001-28911 CANNABIS SCIENC

May 21, 2010 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2010

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2010 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Numb

May 18, 2010 NT 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER< br>137648101 [ ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ X ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Perio

May 11, 2010 CORRESP

CANNABIS SCIENCE, INC. 6946 N. Academy Blvd. Suite B No. 254 Colorado, CO. 80918

CANNABIS SCIENCE, INC. 6946 N. Academy Blvd. Suite B No. 254 Colorado, CO. 80918 May 11, 2010 Via EDGAR Mr. Gary Newberry U.S. Securities & Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 Dear Mr. Newberry: RE: Cannabis Science, Inc. Item 4.02 Form 8-K File No. 0-28911 Following are responses to your comment letter dated April 13, 2010. Form 8-K filed April 9

May 11, 2010 8-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2010

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2010 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (

May 5, 2010 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K þ ANNUAL REPORT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2009 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH E SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-28911 CANNABIS SCIENCE, INC. (Exact name of r

April 9, 2010 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2010

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2010 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Nu

April 1, 2010 NT 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 < b>FORM 12b-25 NOTIFICATION OF LATE FILING (Check one):

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 < b>FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): OMB APPROVAL OMB Number: 3235-0058 Expires: May 31, 2012 Estimated average burden hours per response .... 2.50 SEC FILE NUMBER 000-28911 CUSIP NUMBER 137648101 [ x ] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form 10-D [ ] Form N-SAR [ ] Form N-CSR For Perio

March 18, 2010 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30,

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NU

March 18, 2010 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 [ ] TRAN SITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBE

March 18, 2010 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 2 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 2 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2009 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER

March 17, 2010 CORRESP

CANNABIS SCIENCE, INC. 6946 N. Academy Blvd. Suite B No. 254 Colorado, CO. 80918

CANNABIS SCIENCE, INC. 6946 N. Academy Blvd. Suite B No. 254 Colorado, CO. 80918 March 17, 2010 Via EDGAR Mr. Gary Newberry U.S. Securities & Exchange Commission Division of Corporate Finance 100 F Street NE Washington, DC 20549 Dear Mr. Newberry: RE: Cannabis Science, Inc. Form 10-K for the Fiscal Year Ended December 31, 2008 Filed April 15, 2009 Form 10-K/A for the Fiscal Year Ended December 31,

May 28, 2009 S-8

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 CANNABIS SCIENCE, INC. (Exact name of Registrant as specified in its charter) Nevada 91-1869677 (State or other jurisdiction of incorporation or organization) (IRS Employer Identification No.) 548 Market Street, Suite 16645 San Francisco, California 94104 (Addres

May 28, 2009 EX-4.1

CANNABIS SCIENCE, INC. 2009 STOCK COMPENSATION PLAN SECTION 1

CANNABIS SCIENCE, INC. 2009 STOCK COMPENSATION PLAN SECTION 1 INTRODUCTION 1.1 Establishment. Cannabis Science, Inc. (the ?Company?), a Nevada corporation, hereby establishes the Cannabis Science, Inc. 2009 Non-qualified Stock Plan (the ?Plan?) for employees, consultants, directors, and other persons associated with the Company and any of the Company?s subsidiaries, whom the Board wishes to incite

May 15, 2009 EX-3.1

Certificate of Amendment to Articles of Incorporation For Nevada Profit Corporations (Pursuant to NRS 78.385 and 78.390 – After Issuance of Stock)

EX-3.1 2 ex3one.htm CERTIFICATE OF AMENDMENT Seal ROSS MILLER Secretary of State 204 North Carson Street, Ste 1 Carson City, Nevada 88701-5706 Filed in the office of /s/ Ross Miller Ross Miller Secretary of State State of Nevada Document Number 20090324938-90 Filing Date and Time 04/06/2009 3:00 PM CERTIFICATE OF AMENDMENT (PURSUANT TO NRS 78.385 AND 78.390) Entity Number E0315782007-3 Certificate

May 15, 2009 10-Q

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [ X ]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 [ ]TRANSITION REPORT UNDER SECTI

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [ X ]QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2009 OR [ ]TRANSITION REPORT UNDER SECTION 13 OF 15(d) OF THE EXCHANGE ACT OF 1934 From the transition period from to . Commission File Number 000-51750 CANNABIS SCIENCE, INC. (Exact name

May 15, 2009 8-K

Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) off The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 6, 2009 CANNABIS SCIENCE, INC. (Exact name of registrant as specified in charter) Nevada 000-28911 91-1869677 (State or other jurisdiction of incorporation) (Commission File Nu

May 15, 2009 SC 13D

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Cannabis Science, Inc. (Name of Issuer)

SC 13D 1 kdsc13d5809.htm K&D EQUITY INVESTMENTS, INC. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Cannabis Science, Inc. (Name of Issuer) Common Stock ($.001 Par Value) (Class of Securities) 137648 101 (CUSIP Number) 4310 Wiley Post Rd., Ste. 201 Addison, TX 75001 Address copy to: Michele Sheriff, President K&D Equity

May 14, 2009 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 3 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2007 [ ] TR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 3 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2007 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 000-28

May 14, 2009 10-K/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 [ ] TR

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2008 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 000-28

May 14, 2009 10-Q/A

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2008 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER

April 15, 2009 EX-14.1

Code of Ethical and Professional Standards of Gulf Oil& Gas, Inc. and Affiliated Entities

EXHIBIT 14.1 Code of Ethical and Professional Standards of Gulf Oil& Gas, Inc. and Affiliated Entities Core Principal: Gulf Onshore, Inc. and its related affiliates ("Gulf") will conduct its business honestly and ethically wherever we may conduct business. We will constantly improve the quality or our services, products and operations and will maintain a reputation for honesty, respect, responsibi

April 15, 2009 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 Commission File No. 001-28911 GULF ONSH

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2008 Commission File No. 001-28911 GULF ONSHORE, INC. Nevada (State or other jurisdiction of incorporation or organization) 01-28911 91-1869677 (Commission File Number) (IRS Employer Identificat

April 7, 2009 EX-99.2

GULF Acquires Assets of Cannex Therapeutics LLC Will Develop Medical Cannabis Pharmaceutical Products

GULF Acquires Assets of Cannex Therapeutics LLC Will Develop Medical Cannabis Pharmaceutical Products For Immediate Release March 30, 2009 ADDISON, TX - Gulf Onshore Inc (OTCBB: GFON.

April 7, 2009 EX-99.1

Gulf Onshore, Inc. Resolution of Board of Directors

Gulf Onshore, Inc. Resolution of Board of Directors The directors of Gulf Onshore, Inc., a Nevada corporation (the “Company”), acting pursuant to the Corporate By-Laws and relevant provisions of the Nevada Revised Statutes, waived notice of meeting and rules of procedure for purposes of a telephonic meeting held this March 27, 2009. The meeting as duly called by the Chairman; in attendance, by tel

Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista